One shot could shield indigenous babies from deadly RSV
NCT ID NCT07578298
First seen May 15, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study tests whether a single dose of an RSV-fighting antibody, given at 6 months old, can prevent serious lung infections in Aboriginal and Torres Strait Islander infants. Around 1,000 babies will either receive the antibody or standard care, and researchers will track infections and hospital visits for a year. The goal is to reduce the high rates of RSV illness in these communities.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY INFECTION VIRUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Menzies School of Health Research
Darwin, Northern Territory, 0810, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.